News

Commonwealth Government to proceed with R&D tax cut

The billion dollar cut in the R&D Tax Incentive is one of 21 savings measures the Turnbull government has included in an omnibus Bill it will put to parliament when it resumes at the end of August. The…

Melbourne ranked world’s most liveable city for sixth consecutive year by EIU

Melbourne is the world’s most liveable city for a sixth consecutive year, according to the Economist Intelligence Unit (EIU).The EIU index scores 140 of the world’s major cities in healthcare, education, stability, culture, environment and infrastructure. Melbourne scored…

Study shines new light on programmed cell death

12th August, 2016 A form of regulated cell death known as necroptosis – and its role in health and disease – is the topic of new research by Walter and Eliza Hall Institute scientists. An international team of…

Medtech Trade Mission Going Ahead – Limited Places Still Available!

BioMelbourne Network, on behalf of the State Government of Victoria, is leading a major Medtech Mission to the United States including AdvaMed 2016 – the largest annual medical technology conference on the US calendar. There are still limited…

BioMelbourne Network Members Invited to Meet with International Medtronic Diabetes Representative

US based Medtronic representative, Dr Huzefa Neemuchwala, will be in Melbourne this month.  BioMelbourne Network member organisations are invited to meet with Dr Neemuchwala. Interested organisations, please contact Dr Krystal Evans on 9667 6161 Dr Huzefa Neemuchwala, PhD MBA,…

FULLY BOOKED – Free Seminar with Dr Gerald Chan – The Role of Universities in the Innovation Ecosystem

THIS SEMINAR IS FULLY BOOKED The BioMelbourne Network and Biomedical Research Victoria present international guest speaker, Dr Gerald Chan, CEO, Morningside, USA Free Seminar:  The Role of Universities in the Innovation Ecosystem With Australia’s changing economy, the role of universities…

Minister announces details of Biomedical Translation Fund

Innovation Minister Greg Hunt and Health Minister Sussan Ley have announced the details of the $500 million Biomedical Translation Fund (BTF), including the guidelines. In a joint statement with Health Minister Sussan Ley, Mr Hunt said the Government’s…

Big step towards cure for lifelong viral infections

New research has taken us a step closer to finding a cure for human immunodeficiency virus (HIV), as well as other infections including the glandular fever virus, which is associated with the development of lymphoma. Some infections, such…

Breakthrough lung cancer drug discovery by Melbourne researchers

26th July, 2016 A BREAKTHROUGH discovery has opened up a potential new drug to stop lung cancer and emphysema as well as detecting the killer diseases much sooner. Researchers from Melbourne’s Hudson Institute of Medical Science have identified…

Monash part of world-first clinical trial for lymphoma patients

26th July, 2016 A novel therapy for aggressive lymphoma is being tested in a world-first clinical trial at the Monash Health Translation Precinct (MHTP).In early 2015, researchers at Monash University and Peter MacCallum Cancer Centre showed the novel…

Burnet Institute and ARTES join forces to develop novel hepatitis C vaccine

27th July, 2016 The Melbourne based Burnet Institute and ARTES Biotechnology announce they have joined forces to develop a novel, effective vaccine to prevent transmission of hepatitis C virus (HCV). An HCV vaccine is urgently needed to prevent…

Opthea Reports Positive Data from wet AMD Clinical Trial

26th July, 2016 Melbourne, Australia, July 26 2016 – Opthea Limited (ASX:OPT) • Phase 1 dose escalation study met primary objective demonstrating OPT-302 safety and tolerability as monotherapy and in combination with standard of care Lucentis® • Changes…

Home

News & opinion

Member Directory

Events